BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8870066)

  • 1. Acute stimulant response prediction of chronic trazodone effects.
    Little KY; Gay TL
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):815-24. PubMed ID: 8870066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Amphetamine versus methylphenidate effects in depressed inpatients.
    Little KY
    J Clin Psychiatry; 1993 Sep; 54(9):349-55. PubMed ID: 8407854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and efficacy of high-dose moclobemide alone and in combination with lithium and trazodone.
    Magder DM; Aleksic I; Kennedy SH
    J Clin Psychopharmacol; 2000 Jun; 20(3):394-5. PubMed ID: 10831036
    [No Abstract]   [Full Text] [Related]  

  • 4. Occurrence of trazodone-induced delirium.
    Lennkh C; Fischer P; Küfferle B; Kasper S
    Int Clin Psychopharmacol; 1998 Sep; 13(5):225-8. PubMed ID: 9817628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate for alpha-interferon induced depression.
    Camacho A; Ng B
    J Psychopharmacol; 2006 Sep; 20(5):687-9. PubMed ID: 16533869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.
    Stryjer R; Rosenzcwaig S; Bar F; Ulman AM; Weizman A; Spivak B
    Clin Neuropharmacol; 2010; 33(5):219-22. PubMed ID: 20838215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.
    Mihara K; Yasui-Furukori N; Kondo T; Ishida M; Ono S; Ohkubo T; Osanai T; Sugawara K; Otani K; Kaneko S
    Ther Drug Monit; 2002 Aug; 24(4):563-6. PubMed ID: 12142643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary study of serotonergic antidepressants in treatment of dysthymia.
    Rosenthal J; Hemlock C; Hellerstein DJ; Yanowitch P; Kasch K; Schupak C; Samstag L; Winston A
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):933-41. PubMed ID: 1513932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone.
    Van Bemmel AL; Beersma DG; Van den Hoofdakker RH
    J Affect Disord; 1995 Oct; 35(1-2):11-9. PubMed ID: 8557883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trazodone for the treatment of depression in alcoholics.
    Hershberg PI
    J Subst Abuse Treat; 1995; 12(4):297. PubMed ID: 8830157
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
    Le Bon O; Murphy JR; Staner L; Hoffmann G; Kormoss N; Kentos M; Dupont P; Lion K; Pelc I; Verbanck P
    J Clin Psychopharmacol; 2003 Aug; 23(4):377-83. PubMed ID: 12920414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trazodone in major affective disorders.
    Feighner JP
    Psychopathology; 1984; 17 Suppl 2():15-23. PubMed ID: 6425917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid synergistic effects of lithium and antidepressants.
    Terao T
    Psychopharmacology (Berl); 1995 Nov; 122(2):206-7. PubMed ID: 8848539
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term treatment of double depression: a preliminary study with serotonergic antidepressants.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Hemlock C; Kasch K; Samstag LW; Winston A
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):139-47. PubMed ID: 8115668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma trazodone concentrations and clinical response in elderly depressed patients: a preliminary study.
    Monteleone P; Gnocchi G; Delrio G
    J Clin Psychopharmacol; 1989 Aug; 9(4):284-7. PubMed ID: 2768543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M; Vandoolaeghe E; Desnyder R
    J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trazodone and spontaneous orgasms in an elderly postmenopausal woman: a case report.
    Purcell P; Ghurye R
    J Clin Psychopharmacol; 1995 Aug; 15(4):293-5. PubMed ID: 7593719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.